To examine whether EHMT2 expression is de-regulated in ERMS, and if it is functionally relevant in these tumor subtype, we first examined its expression in 16 ERMS patient tumor sections. This evidence concerns the gene EHMT2 and embryonal rhabdomyosarcoma.